The ins and outs of lipoprotein(a) assay methods

Arch Med Sci Atheroscler Dis. 2023 Dec 30:8:e128-e139. doi: 10.5114/amsad/176653. eCollection 2023.

Abstract

Pathophysiological, epidemiological and genetic studies convincingly showed lipoprotein(a) (Lp(a)) to be a causal mediator of atherosclerotic cardiovascular disease (ASCVD). This happens through a myriad of mechanisms including activation of innate immune cells, endothelial cells as well as platelets. Although these certainties whether or not Lp(a) is ready for prime-time clinical use remain debated. Thus, remit of the present review is to provide an overview of different methods that have been employed for the measurement of Lp(a). The methods include dynamic light scattering, multi-angle light scattering analysis, near-field imaging, sedimentation, gel filtration, and electron microscopy. The development of multiple Lp(a) detection methods is vital for improved prediction of ASCVD risk.

Keywords: ASCVD; Lp(a); apo(a); apo(a) size evaluation; lipoprotein (a).